Cargando…
Smooth Muscle Myosin Inhibition: A Novel Therapeutic Approach for Pulmonary Hypertension
OBJECTIVE: Pulmonary hypertension remains a major clinical problem despite current therapies. In this study, we examine for the first time a novel pharmacological target, smooth muscle myosin, and determine if the smooth muscle myosin inhibitor, CK-2019165 (CK-165) ameliorates pulmonary hypertension...
Autores principales: | Ho, David, Chen, Li, Zhao, Xin, Durham, Nicquanna, Pannirselvam, Malar, Vatner, Dorothy E., Morgans, David J., Malik, Fady I., Vatner, Stephen F., Shen, You-Tang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3341368/ https://www.ncbi.nlm.nih.gov/pubmed/22563487 http://dx.doi.org/10.1371/journal.pone.0036302 |
Ejemplares similares
-
“Smooth Muscle Cell Stiffness Syndrome”—Revisiting the Structural Basis of Arterial Stiffness
por: Sehgel, Nancy L., et al.
Publicado: (2015) -
Models of longevity (Calorie Restriction and AC5 KO): Result of three bad hypotheses
por: Vatner, Stephen F., et al.
Publicado: (2012) -
Inhibition of Adenylyl Cyclase Type 5 Increases Longevity and Healthful Aging through Oxidative Stress Protection
por: Vatner, Stephen F., et al.
Publicado: (2015) -
Exercise enhancement by RGS14 disruption is mediated by brown adipose tissue
por: Vatner, Dorothy E., et al.
Publicado: (2023) -
Adenylyl Cyclase Type 5 Deficiency Protects Against Diet-Induced Obesity and Insulin Resistance
por: Ho, David, et al.
Publicado: (2015)